179 research outputs found

    Association of Urinary Dickkopf-3 with Residual Renal Function Decline in Patients Undergoing Peritoneal Dialysis

    Get PDF
    Background and Objectives: Urinary levels of dickkopf-3 (DKK-3) are associated with poor renal survival in patients with non-dialytic chronic kidney disease. However, it remains unknown whether urinary DKK-3 levels can predict residual renal function (RRF) decline in patients undergoing peritoneal dialysis (PD). Therefore, we investigated the correlation between urinary levels of DKK-3 and the subsequent rate of RRF decline in PD patients. Materials and Methods: This study included 36 PD patients who underwent multiple peritoneal equivalent tests during 2011–2021. The relationship between baseline clinical characteristics and the subsequent annual rate of Kt/V decline was investigated. Results: The annual rate of renal Kt/V decline was 0.29 (range: 0.05–0.48), which correlated with renal Kt/V (r = 0.55, p = 0.0005) and 24 h urinary DKK-3 excretion (r = 0.61, p < 0.0001). Similarly, 24 h urinary DKK-3 excretion (β = 0.44, p = 0.0015) and renal Kt/V (β = 0.38, p = 0.0059) were independently associated with the annual rate of renal Kt/V decline in multivariate analyses. Conclusions: Urinary DKK-3 assessment may help identify PD patients at a high risk of RRF decline

    Muscle-specific deletion of BDK amplifies loss of myofibrillar protein during protein undernutrition

    Get PDF
    Ishikawa, T., Kitaura, Y., Kadota, Y. et al. Muscle-specific deletion of BDK amplifies loss of myofibrillar protein during protein undernutrition. Sci Rep 7, 39825 (2017). https://doi.org/10.1038/srep3982

    A safeguard system for induced pluripotent stem cell-derived rejuvenated T cell therapy

    Get PDF
    The discovery of induced pluripotent stem cells (iPSCs) has created promising new avenues for therapies in regenerative medicine. However, the tumorigenic potential of undifferentiated iPSCs is a major safety concern for clinical translation. To address this issue, we demonstrated the efficacy of suicide gene therapy by introducing inducible caspase-9 (iC9) into iPSCs. Activation of iC9 with a specific chemical inducer of dimerization (CID) initiates a caspase cascade that eliminates iPSCs and tumors originated from iPSCs. We introduced this iC9/CID safeguard system into a previously reported iPSC-derived, rejuvenated cytotoxic T lymphocyte (rejCTL) therapy model and confirmed that we can generate rejCTLs from iPSCs expressing high levels of iC9 without disturbing antigen-specific killing activity. iC9-expressing rejCTLs exert antitumor effects in vivo. The system efficiently and safely induces apoptosis in these rejCTLs. These results unite to suggest that the iC9/CID safeguard system is a promising tool for future iPSC-mediated approaches to clinical therapy

    Conservative treatment of deep dentin lesions in primary molars: Case-series

    Get PDF
    Objective: To carry out a descriptive analysis of a case-series in which the indirect pulp capping (IPC) has been performed for treating primary molars with extensive caries lesions in dentin, in the Private of Specialization in Pediatric Dentistry. Material and Methods: A single calibrated examiner evaluated the medical records of 155 patients aged 2 to 13 years attended at the Foundation for Scientific and Technological Development of Dentistry (FUNDECTO) partnership the University of São Paulo (USP) in 2011-2013 in search of extensive caries lesions treated during this period. Were found only 20 deep caries lesions and with satisfactory clinical and radiographic documentation. Then, the materials and techniques used were collected, as well as instant success described after treatment and observation for no progression of the disease (pain, abscess or fistula). Results: The 20 lesions evaluated reached at least 2/3 of the dentin thickness and were active. In 70% of cases, the restorations were carried out with high viscosity or encapsulated glass ionomer cement, and in 30% of case with light-cured resin. In only one case was used calcium hydroxide cement as liner material before inserting resin. In the teeth treated, only three cases were considered failures. Conclusion: Regardless of the restorative material used and the technique employed, good immediate success rates of the conservative treatment in deep dentin lesions were found, which consequently reduces the risk of exposure and pulp intervention

    Mast Cell Infiltration is Associated with Myelofibrosis and Angiogenesis in Myelodysplastic Syndromes

    Get PDF
    Myelodysplastic syndromes are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by persistent peripheral cytopenia with morphological and functional abnormalities of hematopoietic cells. Mast cells infiltrate into or around tumor tissues and play a role in remodeling of the stromal microenvironment, contributing to tumor progression. Increased mast cell numbers are associated with fibrosis, angiogenesis and a poor prognosis in human carcinomas. The aim of this study was to determine whether mast cell infiltration contributes to myelofibrosis or angiogenesis in myelodysplastic syndromes. We evaluated the correlation between mast cell density and the extent of myelofibrosis and angiogenesis in myelodysplastic syndromes. Fifty bone marrow biopsies taken from patients with a diagnosis of myelodysplastic syndromes were examined. Grading of myelofibrosis was evaluated by silver impregnation staining. Mast cell density and microvessel density were evaluated by immunohistochemistry. Human mast cells have been divided into two phenotypes. We designated a tryptase-positive mast cell as MCT and a chymase-positive mast cell as MCTC. Microvessels were identified by CD34-positive endothelial cells. Microvessel density and the extent of myelofibrosis were significantly greater in patients with high MCT and MCTC density compared to those with low MC density. Based on this, we suggest that the presence of high mast cell numbers is associated with myelofibrosis and angiogenesis in myelodysplastic syndromes

    SHARAQ Project: Progress in 2009

    Get PDF
    On March 23, 2009, the first beam was successfullytransported to the final focal plane of the SHARAQspectrometer. We investigated detector responses toheavy-ion beams and the ion optical properties ofthe SHARAQ spectrometer1) and the high-resolutionbeam line2) in the subsequent commissioning runs andfound that the system as a whole worked almost as perits design. The first physics run with the spectrometerwas performed in November 2009. In this article, wereview the progress in the SHARAQ project in 2009
    corecore